Kenneth Galbraith - Net Worth and Insider Trading

Kenneth Galbraith Net Worth

The estimated net worth of Kenneth Galbraith is at least $350,965 dollars as of 2024-11-05. Kenneth Galbraith is the Chair & CEO of Zymeworks Inc and owns about 23,762 shares of Zymeworks Inc (ZYME) stock worth over $350,965. Kenneth Galbraith is also the Director of Macrogenics Inc and owns about 0 shares of Macrogenics Inc (MGNX) stock worth over $0. Details can be seen in Kenneth Galbraith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Galbraith has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kenneth Galbraith

To

Kenneth Galbraith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth Galbraith owns 3 companies in total, including Macrogenics Inc (MGNX) , Celator Pharmaceuticals Inc (CPXX) , and Zymeworks Inc (ZYME) .

Click here to see the complete history of Kenneth Galbraith’s form 4 insider trades.

Insider Ownership Summary of Kenneth Galbraith

Ticker Comapny Transaction Date Type of Owner
MGNX Macrogenics Inc 2020-09-09 director
CPXX Celator Pharmaceuticals Inc 2013-06-03 director
ZYME Zymeworks Inc 2024-01-08 director & Chair & CEO

Kenneth Galbraith Latest Holdings Summary

Kenneth Galbraith currently owns a total of 2 stocks. Among these stocks, Kenneth Galbraith owns 23,762 shares of Zymeworks Inc (ZYME) as of January 8, 2024, with a value of $350,965 and a weighting of 100%. Kenneth Galbraith also owns 0 shares of Macrogenics Inc (MGNX) as of September 9, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Kenneth Galbraith

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYME Zymeworks Inc 2024-01-08 23,762 14.77 350,965
MGNX Macrogenics Inc 2020-09-09 0 3.81 0

Holding Weightings of Kenneth Galbraith


Kenneth Galbraith Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth Galbraith has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zymeworks Inc is the sale of 23,904 shares on January 8, 2024, which brought Kenneth Galbraith around $257,924.

According to the SEC Form 4 filings, Kenneth Galbraith has made a total of 1 transactions in Macrogenics Inc (MGNX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Macrogenics Inc is the sale of 20,773 shares on September 9, 2020, which brought Kenneth Galbraith around $563,156.

Insider Trading History of Kenneth Galbraith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth Galbraith Trading Performance

GuruFocus tracks the stock performance after each of Kenneth Galbraith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth Galbraith is 52.06%. GuruFocus also compares Kenneth Galbraith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Galbraith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kenneth Galbraith's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kenneth Galbraith

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Kenneth Galbraith Ownership Network

Ownership Network List of Kenneth Galbraith

No Data

Ownership Network Relation of Kenneth Galbraith

Insider Network Chart

Kenneth Galbraith Owned Company Details

What does Macrogenics Inc do?

Who are the key executives at Macrogenics Inc?

Kenneth Galbraith is the director of Macrogenics Inc. Other key executives at Macrogenics Inc include Acting General Counsel Jeffrey Stuart Peters , SVP & CFO and Secretary James Karrels , and Sr VP & BPD & Manufacturing Thomas Spitznagel .

Macrogenics Inc (MGNX) Insider Trades Summary

Over the past 18 months, Kenneth Galbraith made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .

In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.

Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Macrogenics Inc Insider Transactions

No Available Data

Kenneth Galbraith Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth Galbraith. You might contact Kenneth Galbraith via mailing address: Ocean Park Rpo Po Box 45025, 12851 16th Ave, Surrey A1 V4a9l1.